期刊文献+

α7尼古丁受体基因抑制对SH—SY5Y细胞β淀粉样蛋白生成的影响

Influence of inhibited α7 nicotinic acetyicholine receptor gene expression on the production of β-amyioid peptide in SH-SY5Y cells
原文传递
导出
摘要 目的通过RNA干扰技术抑制神经母细胞瘤细胞(SH-SY5Y细胞)中胡神经型尼古丁乙酰胆碱受体(nAChR)的基因表达,以了解α7nAChR对β淀粉样蛋白(AB)的影响,进一步探讨阿尔茨海默病的发病机制。方法SH-SY5Y细胞转染α7nAChR的小干扰RNA(siRNA),用real-timePCR法和蛋白免疫印迹法分别测定细胞中α7nAChR、β分泌酶两个亚型(BACE1和BACE2)在mRNA和蛋白表达水平的变化;用双抗体夹心酶联免疫吸附法测定Aβ1-42含量的变化。结果转染α7nAChRsiRNA后,与对照组相比,α7nAChRmRNA及蛋白表达水平分别降低了84%和79%(P〈0.01);BACElmRNA及蛋白表达水平分别升高了527%和71%(P〈0.01);BACE2mRNA及蛋白表达水平分别降低了58%和75%(P〈0.01);Aβ1-42含量升高了208%(P〈0.01)。结论α7nAChR基因表达抑制后Aβ含量明显升高,其机制可能与BACE1表达上升和BACE2表达抑制有关,这种改变可能与阿尔茨海默病的发病有一定的关系。 Objective To investigate the influence of inhibited α7 neuronal nicotinic acetylcholine receptor (nAChR) by small interference RNA (siRNA) in SH-SYSY cells and to explore the connection of these changes with the β-amyloid precursor protein (APP) metabolism and the pathogenesis of Alzheimer's disease (AD). Methods The siRNA of α7 nAChR was transfected into SH-SY5Y cells, and the expression of α7 nAChR and two subtypes of β-secretases ( BACE1 and BACE2) at mRNA and protein levels was studied by real-time PCR and Western blot, respectively. The variation of A β1-42 content was detected by ELISA. Results As compared with controls, the expression of α7 nAChR at mRNA and protein levels in the SH-SYSY cells transfected with the α7 nAChR siRNA were decreased by 84% and 79% (P 〈 0. 01 ), respectively. The expressions of BACE1 mRNA and protein levels was increased by 527% and 71% (P 〈 0. 01 ), respectively, while the expression of BACE2 decreased by 58% and 75% (P 〈 0. 01 ), respectively. The A β1-42 content increased by 208% ( P 〈 0. 01 ). Conclusions An inhibited α7 nAChR mRNA induced by siRNA may markedly stimulate the production of A β through the mechanism of increased expression of BACE1 and inhibited expression of BACE2, which may be related to the pathogenesis of AD.
出处 《中华病理学杂志》 CAS CSCD 北大核心 2012年第12期837-841,共5页 Chinese Journal of Pathology
基金 国家自然科学基金(30960123) 贵州省科技厅基金项目(黔科合J字2010[3140].
关键词 阿尔茨海默病 淀粉样Β蛋白前体 淀粉样前体蛋白分泌酶类 受体 胆碱能 Alzheimer disease Amyloid beta-peptides Amyloid precursor protein secretases Receptors, cholinergic
  • 相关文献

参考文献17

  • 1Yahata N, Asai M, Kitaoka S, et al. Anti-Aβ drug screening platform using human iPS cell-derived neurons for the treatment of Alzheimer's disease. PLoS One, 2011,6 (9) : e25788.
  • 2官志忠,齐晓岚.阿尔茨海默病的分子发病机制及其治疗研究进展[J].中华病理学杂志,2008,37(1):11-15. 被引量:38
  • 3Rabe S, Reichwald J, Ammaturo D, et ah The Swedish APP mutation alters the effect of genetically reduced BACEI expression on the APP processing. J Neurochem, 2011 ,119( 1 ) :231-239.
  • 4Ahmed RR, Holler C J, Webb RL, et al. BACE1 and BACE2 enzymatic activities in Alzheimer's disease. J Neurochem, 2010, 112 (4) : 1045-1053.
  • 5Higashitani A, Hashizume T, Sugimoto T, et al. C. elegans RNAi space experiment (CERISE) in Japanese Experiment Module KIBO. Biol Sci Space, 2009, 23(4) :183-187.
  • 6Guan ZZ, Miao H, Tian JY, et al. Suppressed expression of nicotinic acetylcholine receptors by nanomolar beta-amyloid peptides in PC12 cells. J Neural Transm, 2001,108 (12) : 1417- 1433.
  • 7Xie Z, Wroblewska L, Prochazka L, et al. Multi-input RNAi- based logic circuit for identification of specific cancer cells. Science, 2011 , 333 ( 6047 ) : 1307-1311.
  • 8Boddapati S, Levites Y, Sierks MR. Inhibiting β-seeretase activity in Alzheimer's disease cell models with single-chain antibodies specifically targeting APP. J Mol Biol, 2011,405 (2) :436-447.
  • 9Vassar R, Bennett BD, Babu-Khan S, et al. Beta-secretase cleavage of Alzheimer' s amyloid precursor protein by the transmembrane aspartic protease BACE. Science, 1999, 286 (5440) :735-741.
  • 10Yan R, Bienkowski MJ, Shuck ME, et al. Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature, 1999, 402(6761 ) : 533-537.

二级参考文献1

共引文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部